Highstreet Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Highstreet Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26,685	Closed	-$246K	–	450
2019 Q2	$246K	Buy	26,685 +17,415	+188%	+$210K	0.01%	243
2019 Q1	$145K	Sell	9,270 -906	-9%	-$16K	0.01%	262
2018 Q4	$157K	Buy	10,176 +190	+2%	+$3.9K	0.01%	252
2018 Q3	$215K	Buy	9,986 +7,088	+245%	+$165K	0.01%	239
2018 Q2	$70K	Buy	2,898 +2,714	+1,475%	+$55.3K	﹤0.01%	256
2018 Q1	$3K	Buy	+184	New	+$3.59K	﹤0.01%	310
2016 Q3	–	Sell	-3,040	Closed	-$153K	–	149
2016 Q2	$153K	Sell	3,040 -998	-25%	-$53.1K	0.05%	132
2016 Q1	$216K	Sell	4,038 -77,082	-95%	-$4.52M	0.08%	141
2015 Q4	$5.33M	Buy	81,120 +77,972	+2,477%	+$4.82M	1.14%	28
2015 Q3	$178K	Buy	+3,148	New	+$204K	0.06%	130

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

Highstreet Asset Management's TEVA Position: Q3 2019 in Review

Highstreet Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 26,685 shares — an estimated $246K sold.

Highstreet Asset Management first reported a position in TEVA in Q3 2015 and held it in 10 quarters. The position peaked at $5.33M in Q4 2015. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

Highstreet Asset Management reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Highstreet Asset Management sold 26,685 Teva Pharmaceuticals shares in Q3 2019, an estimated $246K.
Highstreet Asset Management first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 10 quarters.
Highstreet Asset Management's Teva Pharmaceuticals position peaked at $5.33M in Q4 2015.
428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Highstreet Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.